Anti-cd40 antibodies

PK201100218A0Active Publication Date: 2011-04-12BOEHRINGER INGELHEIM INT GMBH
0 Cites 0 Cited by

Patent Information

Application Number
PK201100218
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Filing Date
2011-03-28
Publication Date
2011-04-12
Patent Text Reader

Abstract

A humanized monoclonal antibody or antigen binding fragment of an antibody wherein said antibody or antigen binding fragment of the antibody specifically binds to human CD40 having an antagonistic activity IC50 of less than 1nM and has no agonism up to 100 µg / ml in B cell proliferation and wherein said antibody or antigen binding fragment of the antibody is further characterized in that the antibody or antigen binding fragment of the antibody has an in vivo half life in non-human primates that is at least 10 days.
Need to check novelty before this filing date? Find Prior Art